Repurposing mebendazole against triple-negative breast cancer CNS metastasis
Journal of Neuro-Oncology · 2024-05 · 168 (1) · 125-138
DOI: 10.1007/s11060-024-04654-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neuro-Oncology, online erschienen am 02.04.2024. Verfasst von Adrian J Rodrigues und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Stanford School of Medicine, Stanford, CA, 94305, USA. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Drug Repositioning, Mebendazole, Mice, Nude. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NCRR NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Purpose
Triple-negative breast cancer (TNBC) often metastasizes to the central nervous system (CNS) and has the highest propensity among breast cancer subtypes to develop leptomeningeal disease (LMD). LMD is a spread of cancer into leptomeningeal space that speeds up the disease progression and severely aggravates the prognosis. LMD has limited treatment options. We sought to test whether the common anti-helminthic drug mebendazole (MBZ) may be effective against murine TNBC LMD.
Methods
A small-molecule screen involving TNBC cell lines identified benzimidazoles as potential therapeutic agents for further study. In vitro migration assays were used to evaluate cell migration capacity and the effect of MBZ. For in vivo testing, CNS metastasis was introduced into BALB/c athymic nude mice through internal carotid artery injections of brain-tropic MDA-MB-231-BR or MCF7-BR cells. Tumor growth and spread was monitored by bioluminescence imaging and immunohistochemistry. MBZ was given orally at 50 and 100 mg/kg doses. MBZ bioavailability was assayed by mass spectrometry.
Results
Bioinformatic analysis and migration assays revealed higher migratory capacity of TNBC compared to other breast cancer subtypes. MBZ effectively slowed down migration of TNBC cell line MDA-MB-231 and its brain tropic derivative MDA-MB-231-BR. In animal studies, MBZ reduced leptomeningeal spread, and extended survival in brain metastasis model produced by MDA-MB-231-BR cells. MBZ did not have an effect in the non-migratory MCF7-BR model.
Conclusions
We demonstrated that MBZ is a safe and effective oral agent in an animal model of TNBC CNS metastasis. Our findings are concordant with previous efforts involving MBZ and CNS pathology and support the drug’s potential utility to slow down leptomeningeal spread.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Stanford School of Medicine, Stanford, CA, 94305, USA.
- Department of Neurosurgery, Massachusetts General Hospital, Boston, MA, 02114, USA.
- Department of Neurosurgery, Stanford School of Medicine, Stanford, CA, 94305, USA. sophiac1@stanford.edu.
- Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, China.
- High-Throughput Screening Knowledge Center, Sarafan ChEM-H, Stanford, CA, 94305, USA.
- Vincent Coates Foundation Mass Spectrometry Laboratory, Stanford University, Stanford, CA, 94305, USA.
Förderung
- NIH HHS
- NCRR NIH HHS
- NCI NIH HHS
- National Institutes of Health
- California Breast Cancer Research Program
- METAvivor
- Chinese Government Scholarship
Zitieren
APA
Rodrigues, A. J., Chernikova, S. B., Wang, Y., Trinh, T. T. H., Solow-Cordero, D. E., Alexandrova, L., Casey, K. M., Alli, E., Aggarwal, A., Quill, T., Koegel, A. K., Feldman, B. J., Ford, J. M., & Hayden-Gephart, M. (2024). Repurposing mebendazole against triple-negative breast cancer CNS metastasis. Journal of Neuro-Oncology, 168(1), 125-138. https://doi.org/10.1007/s11060-024-04654-x
Vancouver
Rodrigues AJ, Chernikova SB, Wang Y, Trinh TTH, Solow-Cordero DE, Alexandrova L, et al. Repurposing mebendazole against triple-negative breast cancer CNS metastasis. Journal of Neuro-Oncology. 2024;168(1):125-138. doi:10.1007/s11060-024-04654-x
BibTeX
@article{Rodrigues2024,
author = {Rodrigues, Adrian J and Chernikova, Sophia B and Wang, Yuelong and Trinh, Thy T H and Solow-Cordero, David E and Alexandrova, Ludmila and Casey, Kerriann M and Alli, Elizabeth and Aggarwal, Abhishek and Quill, Tyler and Koegel, Ashley K and Feldman, Brian J and Ford, James M and Hayden-Gephart, Melanie},
title = {Repurposing mebendazole against triple-negative breast cancer CNS metastasis},
journal = {Journal of Neuro-Oncology},
year = {2024},
volume = {168},
number = {1},
pages = {125--138},
doi = {10.1007/s11060-024-04654-x}
}
EUVIMED